Top Medical News
40 minutes ago
Dissatisfaction with body image is common among men receiving androgen deprivation therapy (ADT), a new study has shown. Exercise is seen as a means to counterbalance the side effect of treatment and improve mood.
12 hours ago
Plasma levels of lipoprotein(a) is correlated with coronary severity, but not with cardiovascular events, in patients with stable coronary artery disease (CAD), a recent study has found.
Pearl Toh, 15 hours ago
Adding apalutamide to androgen-deprivation therapy (ADT) significantly extends radiographic progression-free survival (rPFS) and overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC) compared with ADT alone, the TITAN* study shows.
16 hours ago
Cirrhosis is associated with mortality among haemodialysis patients, and those with severe disease have poorer 2-year outcomes, according to a recent study.
19 hours ago
Immunosuppressed patients are at increased risk for postoperative complications, such as surgical site infection and wound dehiscence, following Mohs micrographic surgery (MMS) due to solid organ transplant and immunosuppressive therapy use, according to a new study.
20 hours ago
Total body surface area and age predict mortality among elderly burn patients, a recent study has shown.
22 hours ago
Untreated obstructive sleep apnoea (OSA) raises the risk of late graft dysfunction after orthotropic heart transplant, reports a recent study.
Special Reports
12 Jun 2019
Urogenital infections remain a major reason for women to visit their family physician and their subsequent referral to obstetrics and gynaecology or urology specialists. The association between abnormal vaginal microbiota and an increased risk of contracting sexually transmitted diseases (STDs), as well as an increased rate of preterm labour, indicates the need to better understand and manage urogenital health in women. Probiotics are “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host”. As such, there is a sound rationale for using probiotics to maintain female vaginal and bladder health.
12 Jun 2019
In conjunction with TRB Chemedica’s 30th anniversary, a panel of distinguished speakers shared their insights into the management of the associated disorders surrounding dry eye disease (DED) at the HOPE Symposium.
03 Jun 2019
The 17th Congress of Asia Pacific Federation of Coloproctology held at Kuala Lumpur Convention Centre saw many local and international experts speaking on various topics in the field of coloproctology. In a symposium chaired by Dato’ Dr Meheshinder Singh, a panel of experts from France and India discussed the results of the CHORUS study, which investigated the association between haemorrhoidal disease (HD) and chronic venous disease (CVD), as well as the efficacy of micronized purified flavonoid fraction (MPFF) in HD.
03 May 2019
At a Boehringer Ingelheim-sponsored symposium, held in conjunction with the joint 12th International Diabetes Federation Western PacificRegion Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in Kuala Lumpur, two prominent speakers discussed therapidly evolving treatment landscape for diabetes, focusing on the implications of heart failure (HF) and chronic kidney disease (CKD) in thediabetes continuum.
02 May 2019
At a recent Abbott lunch symposium held in conjunction with the joint 12th International Diabetes FederationWestern Pacific Region Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in KualaLumpur, Professor Shashank R. Joshi extensively discussed the issue of diabetes in obesity and the role of nutritionalintervention in addressing this growing problem.
24 Apr 2019
At the recent 12th IDF-WPR Congress and 10th AASD Scientific Meeting held at Kuala Lumpur Convention Centre, the importance of glycaemic control and the practical management of type 2 diabetes mellitus (T2DM) were highlighted by two international speakers, Dr Sanjay Kalra from India and Professor Jean Claude Mbanya from Cameroon.
23 Apr 2019
Point-of-care ultrasound (POCUS) has become a very popular diagnostic strategy that can be used in a variety of situations. POCUS is defined as a targeted ultrasound examination performed and interpreted by a physician at their patient’s bedside. It is increasingly recognized as a useful extension to physical examination.
Conference Reports
Pearl Toh, 15 Jun 2019
Adding apalutamide to androgen-deprivation therapy (ADT) significantly extends radiographic progression-free survival (rPFS) and overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC) compared with ADT alone, the TITAN* study shows.
Pearl Toh, 13 Jun 2019

Pembrolizumab is noninferior to standard chemotherapy for overall survival (OS) in advanced gastric or gastroesophageal junction (G/GEJ) cancer in the first-line setting, thus providing a potential alternative treatment option for patients with G/GEJ, according to the KEYNOTE-062 study presented at ASCO 2019.

Roshini Claire Anthony, 13 Jun 2019

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

Roshini Claire Anthony, 12 Jun 2019

Women with platinum-sensitive ovarian cancer with germline BRCA mutations who relapsed after previously receiving 2 lines of chemotherapy demonstrated better objective response rates (ORRs) and progression-free survival (PFS) following treatment with olaparib than platinum-based chemotherapy, according to results of the SOLO3* trial.

Pearl Toh, 11 Jun 2019
The novel antibody-drug conjugate enfortumab vedotin showed promising clinical activity in patients with advanced and metastatic urothelial cancer for whom there is a high unmet need, according to the EV-201 study presented at the ASCO 2019 Meeting.
Roshini Claire Anthony, 11 Jun 2019

The reduced mortality/morbidity benefit previously demonstrated with selexipag in patients with pulmonary arterial hypertension (PAH) may be more pronounced when treatment is initiated soon after diagnosis, according to results of a post hoc analysis of the GRIPHON* study presented as a poster at ATS 2019.

Audrey Abella, 10 Jun 2019
Adding induction chemotherapy (IC) with gemcitabine and cisplatin (GP) to a backbone of cisplatin-based chemoradiotherapy (CRT) generated favourable recurrence-free survival (RFS) and overall survival (OS) rates and toxicity profile in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), according to data presented at ASCO 2019.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download